Light Me Up | Clipmarks


	Light Me Up

Moliticon

4-22-2009 2:10 PM

228 views

tags:

neuroenhancement, stimulants, cognition

Moliticon says:

Neuroenhancement is not a goal for those prescribed these drugs for ADD/ADHD. The goals are freedom from distraction and impulsiveness. It concerns me that more profligate use might impact the availability of drugs for this legitimate purpose.

2 Comments |

Add a Comment

4-22-2009 2:42 PM

Antara

I tried modafinal.....and it was ok, but i wouldn't order it again.
Nothing like the fantastic claims I read about....but I don't have these listed disorders, just wanted to see if it would really help with study, etc. For me---not worth it at all!!

4-22-2009 7:21 PM

Aqualung1000

Informative.

Login to Comment. Not a member yet? Sign up

Today's Top Clips

visit the Top Clips page

View the Top Clips from April 22, 2009

Embed This Clip In Your Site...

<div style="margin: 12px 0px; font-family: arial; color: #333333; background: #ffffff; border: solid 4px #e5e5e5; width: 100%; clear: left;"><div class="CM_CTB_Content_Wrap" style="margin: 0px; padding: 0px;background-color: #ffffff;"><div style="border-bottom: solid 1px #dcdcdc; white-space: nowrap; margin-bottom: 8px; background-color: #eeeeee ;background-image: url(http://clipmarks.com/images/source-bg.gif); background-repeat: repeat-x; height: 24px; line-height: 24px; vertical-align: middle; padding-bottom: 4px; color: #666666; font-size: 10px;" ><a href="http://clipmarks.com/clip-to-blog/" title="see clips that are hot right now"><img src="http://content.clipmarks.com/blog_embed/1810c2fd-58b5-461a-810c-746d10b57688/D4F29576-7383-4DB6-9DD7-BD670A387A2E/" alt="" width="19" height="19" border="0" style="vertical-align: middle; margin: 0px 4px; display: inline; border: none; float:none;" /></a>clipped from <a title="http://www.newyorker.com/reporting/2009/04/27/090427fa_fact_talbot?currentPage=all" href="http://www.newyorker.com/reporting/2009/04/27/090427fa_fact_talbot?currentPage=all" style="font-size: 11px;">www.newyorker.com</a></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.newyorker.com/reporting/2009/04/27/090427fa_fact_talbot?currentPage=all">in recent years Adderall and Ritalin, another stimulant, have been adopted as cognitive enhancers: drugs that high-functioning, overcommitted people take to become higher-functioning and more overcommitted. (Such use is “off label,” meaning that it does not have the approval of either the drug’s manufacturer or the Food and Drug Administration.)</blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.newyorker.com/reporting/2009/04/27/090427fa_fact_talbot?currentPage=all"><div align="center"><img src="http://content8.clipmarks.com/blog_cache/www.newyorker.com/img/59D172D7-46EC-4B10-8299-12D568C1620D" alt="Every era has its defining drug. Neuroenhancers are perfectly suited for our efficiency-obsessed, BlackBerry-equipped office culture." /></div></blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.newyorker.com/reporting/2009/04/27/090427fa_fact_talbot?currentPage=all">Drugs such as Adderall can cause nervousness, headaches, sleeplessness, and decreased appetite, among other side effects.</blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.newyorker.com/reporting/2009/04/27/090427fa_fact_talbot?currentPage=all">The demand is certainly there: from an aging population that won’t put up with memory loss</blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.newyorker.com/reporting/2009/04/27/090427fa_fact_talbot?currentPage=all">the drugs in the pipeline are ampakines, which target a type of glutamate receptor in the brain</blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.newyorker.com/reporting/2009/04/27/090427fa_fact_talbot?currentPage=all">Eliminating foggy-headedness seems to be the goal of many users of neuroenhancers.</blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.newyorker.com/reporting/2009/04/27/090427fa_fact_talbot?currentPage=all">three types of cognition: learning, working memory, and cognitive control</blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.newyorker.com/reporting/2009/04/27/090427fa_fact_talbot?currentPage=all">cognitive control—how effectively you can check yourself in circumstances where the most natural response is the wrong one</blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.newyorker.com/reporting/2009/04/27/090427fa_fact_talbot?currentPage=all">Working memory has been likened to a mental scratch pad</blockquote></div><div style="margin: 0px 6px 6px 4px;"><table style="font-size: 11px;border-spacing: 0px;padding: 0px;" cellpadding="0" cellspacing="0" width="100%"><tr><td style="background:transparent;border-width:0px;padding:0px;">&nbsp;</td><td align="right" style="background:transparent;border-width:0px;padding:0px;width:107px" width="107"><a href="http://clipmarks.com/share/D4F29576-7383-4DB6-9DD7-BD670A387A2E/blog/" title="blog or email this clip"><img src="http://content9.clipmarks.com/images/c2b-foot.png" border="0" alt="blog it" width="107" height="17" style="border-width:0px;padding:0px;margin:0px;" /></a></td></tr></table></div></div>

New from the makers of Clipmarks: Amplify.com - Don't just share the news...Amplify it!

Clipmarks: Home; New Clips; Top Clips; Dashboard

Popular Topics: News; Life; Science; Technology; Entertainment

Get Started: Sign Up; Install Clipping Tool; How Clipping Works; Clip-to-Blog™; ClipSearch

Tools and Resources: FAQ; ClipWeek; Top Clippers; Top Tags; Site Map

About Clipmarks: About Us; Contact; Copyright; Privacy; EULA

Search Options

Today's Top Clips